Real-Life Clinical Data of Cabozantinib for Unresectable Hepatocellular Carcinoma

Abstract

In a real-life Western scenario (mostly in a third-line setting), cabozantinib efficacy and safety data were comparable with those reported in its registration trial. Data regarding the prognostic factors might help in patient selection and design of clinical trials.